结果对47例患者进行随访，病死率、靶血管重建率和主要心脏事件发生率分别为2.1%、2.1%和6.4%。

ResultsFor follow-up 47 patients, the mortality, target vessel revascularization ratio and major adverse cardiac events were 2.1%, 2.1%, 6.4%.

youdao

随访至术后6个月，观察两组主要心血管事件发生率（死亡、非致死性心梗、靶血管血运重建术、新发心功能衰竭）。

Main Adverse Cardiac Events: At 6 month follow-up, there didn't exist statistics difference in the incidence of death, non-fatal MI and TVR between two groups.

youdao

主要终点为主要不良心血管事件（MACE），定义为死亡，心肌梗塞（MI），休克和靶血管血运重建（TVR）。

The primary end point used was major adverse cardiac events (MACE), defined as death, myocardial infarction (MI), stroke and target vessel revascularization (TVR).

youdao

30天和一年的住院期间，其主要结局是缓慢流动/无复流现象（SF-NR）的发生，临床终点包括死亡、心肌梗死（MI）、靶病变血管血运重建术（TVR）和主要心脏不良事件（MACE）。

The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.

youdao

30天和一年的住院期间，其主要结局是缓慢流动/无复流现象（SF-NR）的发生，临床终点包括死亡、心肌梗死（MI）、靶病变血管血运重建术（TVR）和主要心脏不良事件（MACE）。

The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.

youdao